peer reviewedWe review what we think to be the major advances in the field of respiratory medicine over the last ten years. We concentrate here on four major diseases i.e. asthma, chronic obstructive pulmonary disease (COPD), lung cancer and chronic respiratory insufficiency due to restrictive disorders. Therapeutic advances are based either on new drugs or on new disease management concepts and, in some cases, on new medical devices. These advances have allowed a reduction in mortality and morbidity in aforementioned diseases
peer reviewedAsthma is a frequent chronic inflammatory disease which is often mistaken for simple br...
peer reviewedThe most important drugs registered and/or launched in Belgium during the last year in ...
Infection with SARS-CoV-2 can affect multiple organ systems with variable severity and is known to f...
peer reviewedThere has been a recent increase in the prevalence of asthma worldwide. Most cases can ...
peer reviewedIndacaterol is a novel ultra long-acting beta 2-agonist (ultra-LABA), given once-daily,...
The COVID-19 pandemic that has swept around the world in early 2020 has changed our daily practice a...
peer reviewedThe UPLIFT study (Understanding Potential Long-term Impacts on Function with Tiotropium...
peer reviewedThe combination of budesonide 160 micrograms/formoterol 4.5 micrograms (Symbicort TH) i...
peer reviewedSummary: As treating severe forms of asthma represents a medical and economical challen...
Lung tumours have a high incidence and cause many deaths worldwide. Despite progresses in treatment ...
Driven by highly specialized medicine, research and the quest for personalization of treatments, onc...
peer reviewedExacerbations in asthma and chronic obstructive pulmonary disease (COPD) are critical e...
peer reviewedPulmonary arterial hypertension (PAH) is a rare disease, characterized by a progressive...
The main pharmacovigilance updates in 2020 are reviewed. Remdesivir in COVID-19: relatively safe but...
peer reviewedThe role of the anti-inflammatory and bronchodilator triple therapy, including a long a...
peer reviewedAsthma is a frequent chronic inflammatory disease which is often mistaken for simple br...
peer reviewedThe most important drugs registered and/or launched in Belgium during the last year in ...
Infection with SARS-CoV-2 can affect multiple organ systems with variable severity and is known to f...
peer reviewedThere has been a recent increase in the prevalence of asthma worldwide. Most cases can ...
peer reviewedIndacaterol is a novel ultra long-acting beta 2-agonist (ultra-LABA), given once-daily,...
The COVID-19 pandemic that has swept around the world in early 2020 has changed our daily practice a...
peer reviewedThe UPLIFT study (Understanding Potential Long-term Impacts on Function with Tiotropium...
peer reviewedThe combination of budesonide 160 micrograms/formoterol 4.5 micrograms (Symbicort TH) i...
peer reviewedSummary: As treating severe forms of asthma represents a medical and economical challen...
Lung tumours have a high incidence and cause many deaths worldwide. Despite progresses in treatment ...
Driven by highly specialized medicine, research and the quest for personalization of treatments, onc...
peer reviewedExacerbations in asthma and chronic obstructive pulmonary disease (COPD) are critical e...
peer reviewedPulmonary arterial hypertension (PAH) is a rare disease, characterized by a progressive...
The main pharmacovigilance updates in 2020 are reviewed. Remdesivir in COVID-19: relatively safe but...
peer reviewedThe role of the anti-inflammatory and bronchodilator triple therapy, including a long a...
peer reviewedAsthma is a frequent chronic inflammatory disease which is often mistaken for simple br...
peer reviewedThe most important drugs registered and/or launched in Belgium during the last year in ...
Infection with SARS-CoV-2 can affect multiple organ systems with variable severity and is known to f...